These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1708910)

  • 41. Long-term survival of patients with intermediate and high grade lymphoma treated with COMLA/ABP.
    Olopade OI; Larson RA; Mick R; Watson SM; Hoffman PC; Ultmann JE; Golomb HM
    Leukemia; 1990 Feb; 4(2):127-31. PubMed ID: 1689439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
    Fisher RI; Miller TP; Dana BW; Jones SE; Dahlberg S; Coltman CA
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):21-5. PubMed ID: 2438778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Sequential alternating chemotherapy of highly malignant non-Hodgkin's lymphomas with VIM-Bleo and CHOP. Initial results].
    Steinke B; Kraft A; Reinold HM; Heim ME; Löffler B; Heidemann E; Richter C; Josten K; Bross K; Hofmann I
    Onkologie; 1989 Feb; 12(1):19-21. PubMed ID: 2469999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of advanced stage intermediate grade non-Hodgkin's lymphomas.
    Liang RH; Chiu EK; Chan TK; Todd D; Loke SL
    Hematol Oncol; 1990; 8(3):147-54. PubMed ID: 1695608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term survival advantage of MACOP-B over CHOP in intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group.
    Wolf M; Matthews JP; Stone J; Cooper IA; Robertson TI; Fox RM
    Ann Oncol; 1997; 8 Suppl 1():71-5. PubMed ID: 9187435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stage I non-Hodgkin's lymphoma treated with doxorubicin-containing chemotherapy with or without radiotherapy.
    Villikka K; Muhonen T; Ristamäki R; Teerenhovi L; Joensuu H
    Acta Oncol; 1997; 36(6):619-24. PubMed ID: 9408153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Response-oriented therapy with CHOP and VIM-Bleo in high-grade malignant non-Hodgkin's lymphomas.
    Steinke B; Krüger HU; Kraft H; Heim ME; Günther E; Arnold H; Busch FW
    Blut; 1988 Jun; 56(6):269-71. PubMed ID: 2454690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD).
    Skarin AT; Canellos GP; Rosenthal DS; Case DC; MacIntyre JM; Pinkus GS; Moloney WC; Frei E
    J Clin Oncol; 1983 Feb; 1(2):91-8. PubMed ID: 6199472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of low-grade and intermediate-grade lymphoma with intensive combination chemotherapy results in long-term, disease-free survival.
    Licht JD; Bosserman LD; Andersen JW; Yeap BY; Klatt MM; Martel JK; Anderson KC; Rosenthal DS; Pinkus G; Skarin AT
    Cancer; 1990 Aug; 66(4):632-9. PubMed ID: 1696844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclophosphamide, vincristine, adriamycin, and prednisone (CHOP) with and without intermediate dose methotrexate for the treatment of non-Hodgkin's lymphomas of diffuse histology.
    Gomez GA; Barcos M; Han T; Henderson ES
    Cancer; 1987 Jul; 60(1):18-24. PubMed ID: 3581030
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment and prognosis of orbital non-Hodgkin's lymphomas.
    Platanias LC; Putterman AM; Vijayakumar S; Recant W; Weichselbaum RR; Bitran JD
    Am J Clin Oncol; 1992 Feb; 15(1):79-83. PubMed ID: 1372464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: the Stanford experience.
    Kwak LW; Wilson M; Weiss LM; Doggett R; Dorfman RF; Warnke RA; Horning SJ
    J Clin Oncol; 1991 Aug; 9(8):1426-31. PubMed ID: 1712837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of maintenance therapy in the treatment of large-cell non-Hodgkin's lymphoma.
    Avilés A; Huerta J; Zepeda G; Guzmán R; Díaz-Maqueo J
    Acta Oncol; 1991; 30(8):959-62. PubMed ID: 1723288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phase II study of cyclophosphamide (C), epirubicin (E), oncovin (O), prednisone (P), methotrexate (M) + leucovorin and bleomycin (B) (CEOP-MB) in intermediate and high grade non-Hodgkin lymphomas.
    Wils J; Smeets J
    J Chemother; 1991 Aug; 3(4):260-3. PubMed ID: 1723424
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A 10-year update of CHOP-Bleo in the treatment of diffuse large-cell lymphoma.
    Lee R; Cabanillas F; Bodey GP; Freireich EJ
    J Clin Oncol; 1986 Oct; 4(10):1455-61. PubMed ID: 2428947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Vibrio cholerae can be encountered even at home].
    Sinisalo M; Oksanen K; Koivisto V; Vikberg V
    Duodecim; 1991; 107(22):1880-3. PubMed ID: 1285425
    [No Abstract]   [Full Text] [Related]  

  • 57. Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin's lymphoma.
    Fisher RI
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S42-6. PubMed ID: 9272133
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Syndrome of persistent generalized lymphadenopathy with development into a gastric lymphoma].
    Aguilar Ligorit E; Guix García J; Escrig Orenga V; Benet Monforte I; García-Conde Bru J
    Sangre (Barc); 1990 Feb; 35(1):64-8. PubMed ID: 1692162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial.
    Levine AM; Wernz JC; Kaplan L; Rodman N; Cohen P; Metroka C; Bennett JM; Rarick MU; Walsh C; Kahn J
    JAMA; 1991 Jul; 266(1):84-8. PubMed ID: 1710673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The response of diffuse large cell and other intermediate grade non-Hodgkin's lymphomas to adriamycin containing combination chemotherapy.
    Lishner M; Slingerland J; Theresa C; Sutcliffe SB
    Leuk Lymphoma; 1994 Mar; 13(1-2):131-6. PubMed ID: 7517744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.